• OPEN AN ACCOUNT
Indian Indices
Sensex
73,852.90 -876.37
( -1.17%)
Global Indices
Nasdaq
51,986.54 -36.87
(-0.07%)
Dow Jones
7,712.39 31.95
(0.42%)
Hang Seng
63,869.15 -1,047.55
(-1.61%)
Nikkei 225
10,731.75 -32.94
(-0.31%)
Forex
USD-INR
94.77 -0.08
(-0.08%)
EUR-INR
106.47 0.12
(0.11%)
GBP-INR
126.26 0.54
(0.43%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Sat Kartar Life Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
93343
INE0NB801022
43.3828165
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SATKARTAR
13.08
208.26
EPS(TTM)
Face Value()
Div & Yield %
10.08
10
0.53
 

Jyothy Labs standalone net profit declines 12.31% in the March 2026 quarter
May 04,2026
Net profit of Jyothy Labs declined 12.31% to Rs 67.52 crore in the quarter ended March 2026 as against Rs 77.00 crore during the previous quarter ended March 2025. Sales rose 7.73% to Rs 717.41 crore in the quarter ended March 2026 as against Rs 665.96 crore during the previous quarter ended March 2025.

For the full year,net profit declined 10.23% to Rs 333.19 crore in the year ended March 2026 as against Rs 371.17 crore during the previous year ended March 2025. Sales rose 3.53% to Rs 2944.29 crore in the year ended March 2026 as against Rs 2843.92 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales717.41665.96 8 2944.292843.92 4
OPM %13.4916.84 -15.2817.58 -
PBDT111.32125.88 -12 512.43549.37 -7
PBT95.51111.33 -14 451.19493.25 -9
NP67.5277.00 -12 333.19371.17 -10